ArticleCancer immunology, immunotherapy : CII2017

PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.

Riki Okita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.